Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy

Urology

Volumn 81, Issue 6, 2013, Pages 1291-1296

  Losa, Andrea ^b   Gadda, Giulio Maria ^b   Lazzeri, Massimo ^b   Lughezzani, Giovanni ^b   Cardone, Giampiero ^b   Freschi, Massimo ^b   Lista, Giuliana ^b   Larcher, Alessandro ^a,b   Nava, Luciano Dante ^b   Guazzoni, Giorgio ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FUNCTIONAL ASSESSMENT OF CANCER THERAPY PROSTATE QUESTIONNAIRE; GLEASON SCORE; HEMATOMA; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; INDWELLING CATHETER; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; TEMPLATE ASSISTED TRANSPERINEAL PROSTATE BIOPSY; TUMOR BIOPSY; URINE RETENTION;

AGED; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; HEMATOMA; HEMATURIA; HEMOSPERMIA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PERINEUM; PROSTATE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; URINARY RETENTION;

EID: 84878617153     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.11.078     Document Type: Article

References (20)

1. J. Ferlay, H.R. Shin, and F. Bray GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 2010 International Agency for Research on Cancer Lyon, France
2. M.M. Center, A. Jemal, and J. Lortet-Tieulent International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
3. Editorial: To screen or not to screen for prostate cancer? Lancet 379 2012 2024
4. M. Lazzeri, and G. Guazzoni Focal therapy meets prostate cancer Lancet 376 2010 1036 1037
5. V. Mouraviev, and J.F. Madden Focal therapy for prostate cancer: pathologic basis Curr Opin Urol 19 2009 161 167
6. Y. Hu, H.U. Ahmed, and T. Carter A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy BJU Int 110 2012 812 820
7. R. Raaijmakers, W.J. Kirkels, and M.J. Roobol Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program Urology 60 2002 826 830
8. T. Makinen, A. Auvinen, and M. Hakama Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective controlled study Urology 60 2002 846 850
9. J.S. Barkun, J.K. Aronson, and L.S. Feldman Evaluation and stages of surgical innovations Lancet 374 2009 1089 1096
10. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
11. W.E. Barzell, and M.R. Melamed Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience Urology 70 2007 27 35
12. K.K. Hodge, J.E. McNeal, and M.K. Terris Random systematic versus directed ultrasound-guided transrectal biopsies of the prostate J Urol 142 1989 71 74 [discussion 74-75]
13. V. Scattoni, M. Raber, and F. Abdollah Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy Eur Urol 57 2010 1 8
14. T.J. Polascik, J.M. Mayes, and F.R. Schroeck Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy Cancer 115 2009 2104 2110
15. M. Tsivian, M. Kimura, and L. Sun Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended BJU Int 105 2010 1089 1092
16. W.E. Barzell, and W.F. Whitmore Transperineal template guided saturation biopsy of the prostate: rationale, indications and technique Urol Times 31 2003 41 42
17. G. Onik, and W. Barzell Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy Urol Oncol 26 2008 506 510
18. G.S. Merrick, W. Taubenslag, and H. Andreini The morbidity of transperineal template-guided prostate mapping biopsy BJU Int 101 2008 1524 1529
19. Taira AV, Merrick GS, Bennett A, et al. Transperineal template-guided mapping biopsy as a staging procedure to select patients bets suited for active surveillance. Am J Clin Oncol. Epub 2012 Feb 2.
20. M. Chrisofos, A.G. Paptsoris, and A. Dellis Can prostate biopsies affect erectile function? Andrologia 38 2006 79 83